138 related articles for article (PubMed ID: 2470425)
1. Chronic effects of tranylcypromine and 4-fluorotranylcypromine on regional brain monoamine metabolism in rats: a comparison with clorgyline.
Greenshaw AJ; Rao TS; Nazarali AJ; Baker GB; Coutts RT
Biol Psychiatry; 1989 Apr; 25(8):1014-20. PubMed ID: 2470425
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines.
Sherry RL; Baker GB; Coutts RT
Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613
[No Abstract] [Full Text] [Related]
3. Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats.
Mousseau DD; Greenshaw AJ
J Neural Transm; 1989; 75(1):73-9. PubMed ID: 2465373
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and chronic phenelzine on regional monoamine metabolism in rats and its potentiation by deuterium substitution.
Juorio AV; Greenshaw AJ; Boulton AA
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):240-5. PubMed ID: 2429193
[TBL] [Abstract][Full Text] [Related]
5. 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration.
Twist EC; Mitchell S; Brazell C; Stahl SM; Campbell IC
Biochem Pharmacol; 1990 Jan; 39(1):161-6. PubMed ID: 1688704
[TBL] [Abstract][Full Text] [Related]
6. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
[TBL] [Abstract][Full Text] [Related]
7. Brain amine concentrations after monoamine oxidase inhibitor administration.
Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
[TBL] [Abstract][Full Text] [Related]
8. Partial attenuation of chronic fluphenazine-induced changes in regional monoamine metabolism by D-alpha-tocopherol in rat brain.
Jackson-Lewis V; Przedborski S; Kostic V; Suber F; Fahn S; Cadet JL
Brain Res Bull; 1991 Feb; 26(2):251-8. PubMed ID: 1707329
[TBL] [Abstract][Full Text] [Related]
9. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Green AR; Youdim MB
Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
[TBL] [Abstract][Full Text] [Related]
10. Chronic tranylcypromine treatment induces functional alpha 2-adrenoceptor down-regulation in rats.
Greenshaw AJ; Nazarali AJ; Rao TS; Baker GB; Coutts RT
Eur J Pharmacol; 1988 Sep; 154(1):67-72. PubMed ID: 2846327
[TBL] [Abstract][Full Text] [Related]
11. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens.
Pepper JP; Baumann MH; Ayestas M; Rothman RB
Brain Res Mol Brain Res; 2001 Mar; 87(2):184-9. PubMed ID: 11245920
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.
Coutts RT; Rao TS; Baker GB; Micetich RG; Hall TW
Cell Mol Neurobiol; 1987 Sep; 7(3):271-90. PubMed ID: 3440283
[TBL] [Abstract][Full Text] [Related]
14. Ring-substituted analogues of tranylcypromine as monoamine oxidase inhibitors.
Sherry RL; Baker GB; Coutts RT; Mousseau DD
J Neural Transm Suppl; 1990; 32():107-12. PubMed ID: 1982446
[TBL] [Abstract][Full Text] [Related]
15. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
Garrett MC; Soares-da-Silva P
Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
[TBL] [Abstract][Full Text] [Related]
16. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
Guldberg HC; Yates CM
Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
[TBL] [Abstract][Full Text] [Related]
17. Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain.
Bolger GT; Lesieur P; Basile AS; Skolnick P
Brain Res; 1988 Jan; 438(1-2):101-7. PubMed ID: 2449929
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys.
Garrick NA; Scheinin M; Chang WH; Linnoila M; Murphy DL
Biochem Pharmacol; 1984 May; 33(9):1423-7. PubMed ID: 6203542
[TBL] [Abstract][Full Text] [Related]
19. Effect of ischemia on hydroxylase cofactor (tetrahydrobiopterin) and monoamine neurotransmitters in rat brain.
Iijima S; Hara K; Suga H; Nakamura S; Kameyama M
Stroke; 1986; 17(3):529-33. PubMed ID: 2424155
[TBL] [Abstract][Full Text] [Related]
20. Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release.
Halladay AK; Kirschner E; Hesse K; Fisher H; Wagner GC
Pharmacol Toxicol; 2001 Nov; 89(5):237-48. PubMed ID: 11881977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
